Harrison, NYNCT07690917Now EnrollingIRB Ready

Non Small Cell Lung Carcinoma NSCLC Clinical Trial in Harrison, NY

Access cutting-edge non small cell lung carcinoma nsclc treatment through this clinical trial at a research site in Harrison. Study-provided care at no cost to qualified participants.

Sponsored by Memorial Sloan Kettering Cancer Center

Quick Self-Assessment

See if you qualify for this Harrison location

Preparing your pre-screening questions…

Expert Care in Harrison

Access non small cell lung carcinoma nsclc specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related non small cell lung carcinoma nsclc treatment provided free

Apply for This Harrison Location

Check if you qualify for this non small cell lung carcinoma nsclc clinical trial in Harrison, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Harrison

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Harrison site if eligible
  4. 4Begin participation

About This Non Small Cell Lung Carcinoma NSCLC Study in Harrison

The researchers are doing this study to test the capabilities of a new total-body PET scanner called the Biograph Vision Quadra. The researchers want to learn whether this scanner can produce better PET/CT images and provide more useful imaging information than standard PET/CT scanners.

Sponsor: Memorial Sloan Kettering Cancer Center

Who Can Participate

Inclusion Criteria

Eligibility Criteria for objective #1:
Patients with histologically-confirmed non-small cell lung carcinoma (NSCLC) with a single or multiple lung nodules.
Patients who are undergoing a planned PET-CT scan at main campus of MSK.
Patients must be ≥ 18 years old Eligibility Criteria for objective #2:
Patients with disease within the chest, abdomen or pelvis, who could benefit from visualizing the pharmacokinetics of radiotracer uptake within all disease sites simultaneously.
Patients with metastatic prostate or head and neck cancer.
Patients with prostate cancer who are undergoing a 68Ga-PSMA or 18F-FDG scan at the main campus of MSK.
Patients with head and neck cancer who are undergoing a 18F-FDG scan at the main campus of MSK
Patients must be ≥ 18 years old Eligibility Criteria for objective #3:
Patients with histologically-confirmed cancer from all three groups (lung cancer, head and neck cancer, prostate cancer).
Patients who are undergoing an 68Ga-PSMA or 18F-FDG or an \[18F\]-fluormisonidazole PET-CT scan at the main campus of MSK.
Patients willing to return to the MITS clinc for late imaging session between 2 to 6 hours after the PET radiotracer injection. (In current practice, FDG is imaged between 1 and 1.5 hours post injection, and FMISO is imaged between 2.5 and 3 hours post injection)
Patients must be ≥ 18 years old

Exclusion Criteria

Patients who suffer from claustrophobia.
Women who are pregnant or breast-feeding.
Patients \< 18 years of age

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Harrison?

Yes, this clinical trial (NCT07690917) has an active research site in Harrison, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Non Small Cell Lung Carcinoma NSCLC Treatment Options in Harrison, NY

If you're searching for non small cell lung carcinoma nsclc treatment options in Harrison, NY, this clinical trial (NCT07690917) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Harrison research site is actively enrolling participants for this clinical trial. You'll receive care from experienced non small cell lung carcinoma nsclc specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all non small cell lung carcinoma nsclc clinical trials near you to find additional studies recruiting in your area.

More Lung Cancer Trials in Harrison, NY

See all lung cancer clinical trials recruiting in Harrison — not just this study.

Browse Lung Cancer Trials in Harrison →

Browse More Trials by Condition

Lung Cancer TrialsLeukemia TrialsSmall Cell Lung Cancer TrialsNon-Small Cell Lung Cancer TrialsSpinal Muscular Atrophy TrialsAll Conditions →

Ready to Join in Harrison?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Harrison, NY